{"transactions":[{"id":905373,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Discovery Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:30:07.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":5872,"price":33.3666,"value":195928.6752,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $32.98 to $33.85. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":146981,"source":{"system":"sec-edgar","filing":"0001193125-26-051534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526051534/ownership.xml","form_type":"4"}},{"id":905372,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Discovery Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:30:07.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":2128,"price":31.5018,"value":67035.8304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $31.02 to $31.75. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":152853,"source":{"system":"sec-edgar","filing":"0001193125-26-051534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526051534/ownership.xml","form_type":"4"}},{"id":935469,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Discovery Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:30:13.000Z","date":"2026-01-12","kind":"sale","planned":true,"acquired":false,"shares":1017,"price":29.0808,"value":29575.1736,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $28.9131 to $29.23. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":154981,"source":{"system":"sec-edgar","filing":"0001193125-26-016651","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526016651/ownership.xml","form_type":"4"}},{"id":935468,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Discovery Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:30:13.000Z","date":"2026-01-12","kind":"sale","planned":true,"acquired":false,"shares":6983,"price":28.442,"value":198610.486,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $27.9083 to $28.84. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":155998,"source":{"system":"sec-edgar","filing":"0001193125-26-016651","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526016651/ownership.xml","form_type":"4"}},{"id":967744,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Discovery Officer"}}],"security":"Common Stock","published_at":"2025-12-16T21:30:09.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":22.6449,"value":181159.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $22.06 to $23.03. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":162981,"source":{"system":"sec-edgar","filing":"0001193125-25-320941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312525320941/ownership.xml","form_type":"4"}},{"id":994015,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-20T00:30:04.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":49956,"price":16.3203,"value":815296.9068,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.04 to $16.68. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":170981,"source":{"system":"sec-edgar","filing":"0001193125-25-288529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312525288529/ownership.xml","form_type":"4"}},{"id":994014,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-20T00:30:04.000Z","date":"2025-11-18","kind":"sale","planned":true,"acquired":false,"shares":75633,"price":16.0727,"value":1215626.5191,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.24. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":220937,"source":{"system":"sec-edgar","filing":"0001193125-25-288529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312525288529/ownership.xml","form_type":"4"}},{"id":997907,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-18T00:03:58.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":17.0713,"value":25606.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.06 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":296570,"source":{"system":"sec-edgar","filing":"0001193125-25-284935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312525284935/ownership.xml","form_type":"4"}},{"id":997906,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-18T00:03:58.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":18572,"price":16.1098,"value":299191.2056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $17.00. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":298070,"source":{"system":"sec-edgar","filing":"0001193125-25-284935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312525284935/ownership.xml","form_type":"4"}},{"id":997905,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-18T00:03:58.000Z","date":"2025-11-14","kind":"sale","planned":true,"acquired":false,"shares":110228,"price":16.0167,"value":1765488.8076,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.13. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":316642,"source":{"system":"sec-edgar","filing":"0001193125-25-284935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312525284935/ownership.xml","form_type":"4"}},{"id":997904,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-18T00:03:58.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":1111,"price":16.0036,"value":17779.9996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.02. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":426870,"source":{"system":"sec-edgar","filing":"0001193125-25-284935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312525284935/ownership.xml","form_type":"4"}},{"id":1072373,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-07T20:40:24.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following August 7, 2025, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":170000,"derivative":{"exercise_price":10.75,"expiration_date":"2035-08-06","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0000950170-25-105140","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025105140/ownership.xml","form_type":"4"}},{"id":1431490,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-16T21:55:56.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following August 14, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":115000,"derivative":{"exercise_price":21.57,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0000950170-24-098179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024098179/ownership.xml","form_type":"4"}},{"id":1485162,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-06-10T23:10:09.000Z","date":"2024-06-10","kind":"sale","planned":true,"acquired":false,"shares":3502,"price":20.0014,"value":70044.9028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.03. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":427981,"source":{"system":"sec-edgar","filing":"0000950170-24-071500","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024071500/ownership.xml","form_type":"4"}},{"id":1485161,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-06-10T23:10:09.000Z","date":"2024-06-07","kind":"sale","planned":true,"acquired":false,"shares":200,"price":20,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022"}],"balance_after":431483,"source":{"system":"sec-edgar","filing":"0000950170-24-071500","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024071500/ownership.xml","form_type":"4"}},{"id":1578969,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-13T21:46:16.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":200,"price":20,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."}],"balance_after":431683,"source":{"system":"sec-edgar","filing":"0000950170-24-030932","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024030932/ownership.xml","form_type":"4"}},{"id":1587065,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-08T22:38:11.000Z","date":"2024-03-07","kind":"sale","planned":true,"acquired":false,"shares":68,"price":20,"value":1360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."}],"balance_after":431883,"source":{"system":"sec-edgar","filing":"0000950170-24-028807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024028807/ownership.xml","form_type":"4"}},{"id":1587064,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-08T22:38:11.000Z","date":"2024-03-06","kind":"sale","planned":true,"acquired":false,"shares":1733,"price":20.092,"value":34819.436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.39. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":431951,"source":{"system":"sec-edgar","filing":"0000950170-24-028807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024028807/ownership.xml","form_type":"4"}},{"id":1597357,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-05T22:40:43.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":1189,"price":20.0189,"value":23802.4721,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.10. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":433684,"source":{"system":"sec-edgar","filing":"0000950170-24-026365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024026365/ownership.xml","form_type":"4"}},{"id":1597356,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-05T22:40:43.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":5063,"price":20.0778,"value":101653.9014,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":434873,"source":{"system":"sec-edgar","filing":"0000950170-24-026365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024026365/ownership.xml","form_type":"4"}},{"id":1597355,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-05T22:40:43.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":2900,"price":20.0386,"value":58111.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":439936,"source":{"system":"sec-edgar","filing":"0000950170-24-026365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024026365/ownership.xml","form_type":"4"}},{"id":1610261,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-29T23:58:21.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":2050,"price":20.0016,"value":41003.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.02. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":442836,"source":{"system":"sec-edgar","filing":"0000950170-24-023406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024023406/ownership.xml","form_type":"4"}},{"id":1610260,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-29T23:58:21.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":5849,"price":20.128,"value":117728.672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.50. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":444886,"source":{"system":"sec-edgar","filing":"0000950170-24-023406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024023406/ownership.xml","form_type":"4"}},{"id":1610259,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-29T23:58:21.000Z","date":"2024-02-27","kind":"sale","planned":true,"acquired":false,"shares":745,"price":20,"value":14900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."}],"balance_after":450735,"source":{"system":"sec-edgar","filing":"0000950170-24-023406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024023406/ownership.xml","form_type":"4"}},{"id":1643434,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-15T02:00:08.000Z","date":"2024-02-12","kind":"sale","planned":true,"acquired":false,"shares":1501,"price":20,"value":30020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."}],"balance_after":451480,"source":{"system":"sec-edgar","filing":"0000950170-24-015559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024015559/ownership.xml","form_type":"4"}},{"id":1651814,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-10T00:26:21.000Z","date":"2024-02-07","kind":"sale","planned":true,"acquired":false,"shares":9587,"price":18.0939,"value":173466.2193,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.48. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":452981,"source":{"system":"sec-edgar","filing":"0000950170-24-013474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024013474/ownership.xml","form_type":"4"}},{"id":1656971,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-07T01:23:04.000Z","date":"2024-02-02","kind":"exercise","planned":true,"acquired":false,"shares":25393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":108110,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":25393},"source":{"system":"sec-edgar","filing":"0000950170-24-011880","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024011880/ownership.xml","form_type":"4"}},{"id":1656970,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-07T01:23:04.000Z","date":"2024-02-06","kind":"sale","planned":true,"acquired":false,"shares":15413,"price":18.0904,"value":278827.3352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":462568,"source":{"system":"sec-edgar","filing":"0000950170-24-011880","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024011880/ownership.xml","form_type":"4"}},{"id":1656969,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-07T01:23:04.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":2300,"price":17.043,"value":39198.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":477981,"source":{"system":"sec-edgar","filing":"0000950170-24-011880","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024011880/ownership.xml","form_type":"4"}},{"id":1656968,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-07T01:23:04.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":73093,"price":16.3066,"value":1191898.3138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.91. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":480281,"source":{"system":"sec-edgar","filing":"0000950170-24-011880","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024011880/ownership.xml","form_type":"4"}},{"id":1656967,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-07T01:23:04.000Z","date":"2024-02-02","kind":"exercise","planned":true,"acquired":true,"shares":25393,"price":0.61,"value":15489.73,"ownership":{"direct":true},"balance_after":553374,"source":{"system":"sec-edgar","filing":"0000950170-24-011880","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024011880/ownership.xml","form_type":"4"}},{"id":1819379,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-01T21:30:11.000Z","date":"2023-07-28","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":110000,"derivative":{"exercise_price":14.35,"expiration_date":"2033-07-27","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-23-044027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123044027/doc4.xml","form_type":"4"}},{"id":1824955,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-22T00:52:50.000Z","date":"2023-07-21","kind":"exercise","planned":true,"acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":133503,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0001209191-23-043165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123043165/doc4.xml","form_type":"4"}},{"id":1824954,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-22T00:52:50.000Z","date":"2023-07-19","kind":"exercise","planned":true,"acquired":false,"shares":207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":137403,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":207},"source":{"system":"sec-edgar","filing":"0001209191-23-043165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123043165/doc4.xml","form_type":"4"}},{"id":1824953,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-22T00:52:50.000Z","date":"2023-07-21","kind":"sale","planned":true,"acquired":false,"shares":3900,"price":16.0071,"value":62427.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.07. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-043165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123043165/doc4.xml","form_type":"4"}},{"id":1824952,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-22T00:52:50.000Z","date":"2023-07-21","kind":"exercise","planned":true,"acquired":true,"shares":3900,"price":0.61,"value":2379.0,"ownership":{"direct":true},"balance_after":531881,"source":{"system":"sec-edgar","filing":"0001209191-23-043165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123043165/doc4.xml","form_type":"4"}},{"id":1824951,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-22T00:52:50.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":207,"price":16.075,"value":3327.525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-043165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123043165/doc4.xml","form_type":"4"}},{"id":1824950,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-22T00:52:50.000Z","date":"2023-07-19","kind":"exercise","planned":true,"acquired":true,"shares":207,"price":0.61,"value":126.27,"ownership":{"direct":true},"balance_after":528188,"source":{"system":"sec-edgar","filing":"0001209191-23-043165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123043165/doc4.xml","form_type":"4"}},{"id":1828829,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-17T23:35:46.000Z","date":"2023-07-17","kind":"exercise","planned":true,"acquired":false,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":137610,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0001209191-23-042495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042495/doc4.xml","form_type":"4"}},{"id":1828828,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-17T23:35:46.000Z","date":"2023-07-13","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":139510,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-23-042495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042495/doc4.xml","form_type":"4"}},{"id":1828827,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-17T23:35:46.000Z","date":"2023-07-17","kind":"sale","planned":true,"acquired":false,"shares":1900,"price":16.0337,"value":30464.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.10. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-042495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042495/doc4.xml","form_type":"4"}},{"id":1828826,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-17T23:35:46.000Z","date":"2023-07-17","kind":"exercise","planned":true,"acquired":true,"shares":1900,"price":0.61,"value":1159.0,"ownership":{"direct":true},"balance_after":529881,"source":{"system":"sec-edgar","filing":"0001209191-23-042495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042495/doc4.xml","form_type":"4"}},{"id":1828825,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-17T23:35:46.000Z","date":"2023-07-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":16.13,"value":8065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.05 and $16.25. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-042495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042495/doc4.xml","form_type":"4"}},{"id":1828824,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-17T23:35:46.000Z","date":"2023-07-13","kind":"exercise","planned":true,"acquired":true,"shares":500,"price":0.61,"value":305.0,"ownership":{"direct":true},"balance_after":528481,"source":{"system":"sec-edgar","filing":"0001209191-23-042495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042495/doc4.xml","form_type":"4"}},{"id":1831005,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T22:41:29.000Z","date":"2023-07-11","kind":"exercise","planned":true,"acquired":false,"shares":201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":140010,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":201},"source":{"system":"sec-edgar","filing":"0001209191-23-042114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042114/doc4.xml","form_type":"4"}},{"id":1831004,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T22:41:29.000Z","date":"2023-07-11","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":140211,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-23-042114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042114/doc4.xml","form_type":"4"}},{"id":1831003,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T22:41:29.000Z","date":"2023-07-10","kind":"exercise","planned":true,"acquired":false,"shares":1202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":140711,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":1202},"source":{"system":"sec-edgar","filing":"0001209191-23-042114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042114/doc4.xml","form_type":"4"}},{"id":1831002,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-12T22:41:29.000Z","date":"2023-07-12","kind":"sale","planned":true,"acquired":false,"shares":201,"price":16.2304,"value":3262.3104,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.07 to $16.39. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-042114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042114/doc4.xml","form_type":"4"}},{"id":1831001,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-12T22:41:29.000Z","date":"2023-07-12","kind":"exercise","planned":true,"acquired":true,"shares":201,"price":0.61,"value":122.61,"ownership":{"direct":true},"balance_after":528182,"source":{"system":"sec-edgar","filing":"0001209191-23-042114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042114/doc4.xml","form_type":"4"}},{"id":1831000,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-12T22:41:29.000Z","date":"2023-07-11","kind":"sale","planned":true,"acquired":false,"shares":500,"price":16.019,"value":8009.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.06. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-042114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042114/doc4.xml","form_type":"4"}},{"id":1830999,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-12T22:41:29.000Z","date":"2023-07-11","kind":"exercise","planned":true,"acquired":true,"shares":500,"price":0.61,"value":305.0,"ownership":{"direct":true},"balance_after":528481,"source":{"system":"sec-edgar","filing":"0001209191-23-042114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042114/doc4.xml","form_type":"4"}},{"id":1830998,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-12T22:41:29.000Z","date":"2023-07-10","kind":"sale","planned":true,"acquired":false,"shares":1202,"price":16.0069,"value":19240.2938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.12. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-042114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042114/doc4.xml","form_type":"4"}},{"id":1830997,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-12T22:41:29.000Z","date":"2023-07-10","kind":"exercise","planned":true,"acquired":true,"shares":1202,"price":0.61,"value":733.22,"ownership":{"direct":true},"balance_after":529183,"source":{"system":"sec-edgar","filing":"0001209191-23-042114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123042114/doc4.xml","form_type":"4"}},{"id":1839846,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T21:31:55.000Z","date":"2023-07-03","kind":"exercise","planned":true,"acquired":false,"shares":4265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":141913,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":4265},"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1839845,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T21:31:55.000Z","date":"2023-06-30","kind":"exercise","planned":true,"acquired":false,"shares":18819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":146178,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":18819},"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1839844,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T21:31:55.000Z","date":"2023-06-29","kind":"exercise","planned":true,"acquired":false,"shares":17281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":164997,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":17281},"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1839843,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-03T21:31:55.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":400,"price":17.035,"value":6814.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1839842,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-03T21:31:55.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":3865,"price":16.3001,"value":62999.8865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16 to $17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":528381,"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1839841,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-03T21:31:55.000Z","date":"2023-07-03","kind":"exercise","planned":true,"acquired":true,"shares":4265,"price":0.61,"value":2601.65,"ownership":{"direct":true},"balance_after":532246,"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1839840,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-03T21:31:55.000Z","date":"2023-06-30","kind":"sale","planned":true,"acquired":false,"shares":18819,"price":16.9732,"value":319418.6508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.45 to $17.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1839839,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-03T21:31:55.000Z","date":"2023-06-30","kind":"exercise","planned":true,"acquired":true,"shares":18819,"price":0.61,"value":11479.59,"ownership":{"direct":true},"balance_after":546800,"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1839838,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-03T21:31:55.000Z","date":"2023-06-29","kind":"sale","planned":true,"acquired":false,"shares":17281,"price":16.4929,"value":285013.8049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.13 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1839837,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-03T21:31:55.000Z","date":"2023-06-29","kind":"exercise","planned":true,"acquired":true,"shares":17281,"price":0.61,"value":10541.41,"ownership":{"direct":true},"balance_after":545262,"source":{"system":"sec-edgar","filing":"0001209191-23-040654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040654/doc4.xml","form_type":"4"}},{"id":1842800,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-28","kind":"exercise","planned":true,"acquired":false,"shares":13524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":182278,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":13524},"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842799,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-27","kind":"exercise","planned":true,"acquired":false,"shares":16028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":195802,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":16028},"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842798,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-26","kind":"exercise","planned":true,"acquired":false,"shares":17232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":211830,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":17232},"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842797,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-28","kind":"sale","planned":true,"acquired":false,"shares":13524,"price":16.906,"value":228636.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.50 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842796,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-28","kind":"exercise","planned":true,"acquired":true,"shares":13524,"price":0.61,"value":8249.64,"ownership":{"direct":true},"balance_after":541505,"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842795,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-27","kind":"sale","planned":true,"acquired":false,"shares":8135,"price":17.0897,"value":139024.7095,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.20. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842794,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-27","kind":"sale","planned":true,"acquired":false,"shares":7893,"price":16.73,"value":132049.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.01. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":536116,"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842793,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-27","kind":"exercise","planned":true,"acquired":true,"shares":16028,"price":0.61,"value":9777.08,"ownership":{"direct":true},"balance_after":544009,"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842792,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-26","kind":"sale","planned":true,"acquired":false,"shares":6370,"price":17.236,"value":109793.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.69. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842791,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-26","kind":"sale","planned":true,"acquired":false,"shares":10862,"price":16.4916,"value":179131.7592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.005. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":534351,"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1842790,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-29T00:31:53.000Z","date":"2023-06-26","kind":"exercise","planned":true,"acquired":true,"shares":17232,"price":0.61,"value":10511.52,"ownership":{"direct":true},"balance_after":545213,"source":{"system":"sec-edgar","filing":"0001209191-23-040105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123040105/doc4.xml","form_type":"4"}},{"id":1854639,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T00:58:03.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":false,"shares":12592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":229062,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":12592},"source":{"system":"sec-edgar","filing":"0001209191-23-037611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037611/doc4.xml","form_type":"4"}},{"id":1854638,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T00:58:03.000Z","date":"2023-06-14","kind":"exercise","planned":true,"acquired":false,"shares":120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":241654,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":120},"source":{"system":"sec-edgar","filing":"0001209191-23-037611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037611/doc4.xml","form_type":"4"}},{"id":1854637,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T00:58:03.000Z","date":"2023-06-13","kind":"exercise","planned":true,"acquired":false,"shares":5628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":241774,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":5628},"source":{"system":"sec-edgar","filing":"0001209191-23-037611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037611/doc4.xml","form_type":"4"}},{"id":1854636,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-16T00:58:03.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":12592,"price":16.1453,"value":203301.6176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.64. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-037611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037611/doc4.xml","form_type":"4"}},{"id":1854635,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-16T00:58:03.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":true,"shares":12592,"price":0.61,"value":7681.12,"ownership":{"direct":true},"balance_after":540573,"source":{"system":"sec-edgar","filing":"0001209191-23-037611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037611/doc4.xml","form_type":"4"}},{"id":1854634,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-16T00:58:03.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":120,"price":16.45,"value":1974.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-037611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037611/doc4.xml","form_type":"4"}},{"id":1854633,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-16T00:58:03.000Z","date":"2023-06-14","kind":"exercise","planned":true,"acquired":true,"shares":120,"price":0.61,"value":73.2,"ownership":{"direct":true},"balance_after":528101,"source":{"system":"sec-edgar","filing":"0001209191-23-037611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037611/doc4.xml","form_type":"4"}},{"id":1854632,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-16T00:58:03.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":5628,"price":16.0144,"value":90129.0432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.38. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-037611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037611/doc4.xml","form_type":"4"}},{"id":1854631,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-16T00:58:03.000Z","date":"2023-06-13","kind":"exercise","planned":true,"acquired":true,"shares":5628,"price":0.61,"value":3433.08,"ownership":{"direct":true},"balance_after":533609,"source":{"system":"sec-edgar","filing":"0001209191-23-037611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037611/doc4.xml","form_type":"4"}},{"id":1932616,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T00:07:43.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":229421,"derivative":{"exercise_price":0.61,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-23-022432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123022432/doc4.xml","form_type":"4"}},{"id":1932615,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T00:07:43.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":231421,"derivative":{"exercise_price":0.61,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001209191-23-022432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123022432/doc4.xml","form_type":"4"}},{"id":1932614,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T00:07:43.000Z","date":"2023-03-30","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":231821,"derivative":{"exercise_price":0.61,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-23-022432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123022432/doc4.xml","form_type":"4"}},{"id":1932613,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-04T00:07:43.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":16.1569,"value":32313.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-022432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123022432/doc4.xml","form_type":"4"}},{"id":1932612,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-04T00:07:43.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":0.61,"value":1220.0,"ownership":{"direct":true},"balance_after":529981,"source":{"system":"sec-edgar","filing":"0001209191-23-022432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123022432/doc4.xml","form_type":"4"}},{"id":1932611,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-04T00:07:43.000Z","date":"2023-03-31","kind":"sale","planned":true,"acquired":false,"shares":400,"price":16.0006,"value":6400.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-022432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123022432/doc4.xml","form_type":"4"}},{"id":1932610,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-04T00:07:43.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":true,"shares":400,"price":0.61,"value":244.0,"ownership":{"direct":true},"balance_after":528381,"source":{"system":"sec-edgar","filing":"0001209191-23-022432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123022432/doc4.xml","form_type":"4"}},{"id":1932609,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-04T00:07:43.000Z","date":"2023-03-30","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":16.0075,"value":32015.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-022432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123022432/doc4.xml","form_type":"4"}},{"id":1932608,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-04T00:07:43.000Z","date":"2023-03-30","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":0.61,"value":1220.0,"ownership":{"direct":true},"balance_after":529981,"source":{"system":"sec-edgar","filing":"0001209191-23-022432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123022432/doc4.xml","form_type":"4"}},{"id":1935874,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T23:53:04.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":false,"shares":2187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":233821,"derivative":{"exercise_price":0.61,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":2187},"source":{"system":"sec-edgar","filing":"0001209191-23-021564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021564/doc4.xml","form_type":"4"}},{"id":1935873,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T23:53:04.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":3346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":236008,"derivative":{"exercise_price":0.61,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":3346},"source":{"system":"sec-edgar","filing":"0001209191-23-021564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021564/doc4.xml","form_type":"4"}},{"id":1935872,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T23:53:04.000Z","date":"2023-03-27","kind":"exercise","planned":false,"acquired":false,"shares":8048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":239354,"derivative":{"exercise_price":0.61,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":8048},"source":{"system":"sec-edgar","filing":"0001209191-23-021564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021564/doc4.xml","form_type":"4"}},{"id":1935871,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-29T23:53:04.000Z","date":"2023-03-29","kind":"sale","planned":false,"acquired":false,"shares":2187,"price":16.2134,"value":35458.7058,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-021564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021564/doc4.xml","form_type":"4"}},{"id":1935870,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-29T23:53:04.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":true,"shares":2187,"price":0.61,"value":1334.07,"ownership":{"direct":true},"balance_after":530168,"source":{"system":"sec-edgar","filing":"0001209191-23-021564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021564/doc4.xml","form_type":"4"}},{"id":1935869,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-29T23:53:04.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":3346,"price":16,"value":53536.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-021564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021564/doc4.xml","form_type":"4"}},{"id":1935868,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-29T23:53:04.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":3346,"price":0.61,"value":2041.06,"ownership":{"direct":true},"balance_after":531327,"source":{"system":"sec-edgar","filing":"0001209191-23-021564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021564/doc4.xml","form_type":"4"}},{"id":1935867,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":66513,"kind":"person","name":"Bensen Daniel","position":1,"cik":"0001880946","reported_name":"Bensen Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-29T23:53:04.000Z","date":"2023-03-27","kind":"sale","planned":false,"acquired":false,"shares":8048,"price":16,"value":128768.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":527981,"source":{"system":"sec-edgar","filing":"0001209191-23-021564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021564/doc4.xml","form_type":"4"}}],"next_cursor":"2023-03-29T23:53:04.000000Z,1935867"}